Concord Wealth Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25
Closed -$3.21K 1262
2022
Q4
$3.21K Buy
+25
New +$3.23K ﹤0.01% 853
2022
Q3
Sell
-25
Closed -$4K 1247
2022
Q2
$4K Sell
25
-47
-65% -$6.77K ﹤0.01% 908
2022
Q1
$10K Buy
72
+8
+13% +$1.08K ﹤0.01% 792
2021
Q4
$10K Buy
64
+59
+1,180% +$9.88K ﹤0.01% 795
2021
Q3
$1K Buy
+5
New +$778 ﹤0.01% 882
2021
Q1
Sell
-5
Closed -$1K 1078
2020
Q4
$1K Buy
+5
New +$932 ﹤0.01% 671

Other funds holding SGEN

Concord Wealth Partners's SGEN Position: Q1 2023 in Review

Concord Wealth Partners sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 25 shares — an estimated $3.21K sold.

Concord Wealth Partners first reported a position in SGEN in Q4 2020 and held it in 6 quarters. The position peaked at $10K in Q1 2022. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.

  • Concord Wealth Partners reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Concord Wealth Partners sold 25 Seagen Inc. Common Stock shares in Q1 2023, an estimated $3.21K.
  • Concord Wealth Partners first reported a position in Seagen Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Concord Wealth Partners's Seagen Inc. Common Stock position peaked at $10K in Q1 2022.
  • 575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.

Based on Concord Wealth Partners's 13F filing for Q1 2023, filed 26 Apr 2023.